Published Date: 05 Apr 2023
Almost one in five adults in America has diabetes. The common condition is not, however, easy to manage or treat. The No. 1 cause of death worldwide is diabetes and its complications. One of the main causes of lower-limb and adult blindness.
Read Full NewsPolverino stresses the need for prospective analysis to validate CC16 and mucus plugs as viable biomarkers for COPD status.
In a recently published study, integrating prehospital GFAP measurements with established stroke scales significantly improved the accuracy of large vessel occlusion detection in patients with acute stroke.
Here's some of what is coming soon to NeurologyLive® this week.
Inside MS: A Clinician's Compass, a podcast hosted by neuroimmunologist Lindsay Ross, MD, brings you an exclusive interview with Edith Graham, MD. [LISTEN TIME: 40 minutes]
Sands explains the potential benefits of obefazimod and reviews findings from ABTECT 1 and ABTECT 2 presented at ACG 2025.
In this end-of-year reel, HCPLive has showcased several key highlights from the Skin of Color Savvy podcast in 2025.
This episode of Skin of Color Savvy was filmed on-site at the Skin of Color Society's 'Meeting the Challenge Summit' in Washington, DC.
1.
Telemedicine services linked to reducing excess mortality
2.
Two-part prodrug system activates immune attack only in tumor's unique environment
3.
Is a $2,000 Whole-Body MRI Worth It?
4.
Video: How to treat kidney disease?
5.
As compared to proton therapy, proton therapy is very effective in treating esophageal cancer.
1.
Strategic Deals and FDA Approvals Transforming U.S. Oncology Drug Development
2.
Unmasking the Subtle Symptoms of Colon Cancer
3.
Unlocking the Potential of Bicalutamide 50 mg: A Revolutionary New Treatment for Prostate Cancer
4.
Unlocking the Secrets of Squamous Cell Carcinoma: New Hope for Patients
5.
Unveiling the Mystery of Castleman's Disease: A Journey to Better Health
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Iron Deficiency Anemia: Ferric Maltol As a New Treatment Option
2.
Efficient Management of First line ALK-rearranged NSCLC - Part II
3.
INO-VATE: The Long-Term Overall Survival Analysis in Iontuzumab-Treated Patients
4.
The Comprehensive Impact of CDK4/6 Inhibition in HR+/HER2- Metastatic Breast Cancer: Insights from PALOMA-2.
5.
Navigating the Complexities of Ph Negative ALL - Part XIII
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation